Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 5, 2001New England Journal of MedicineOpen Access

Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

CEChristine M. EngBaylor College of MedicineNGNathalie GuffonHôpital Femme Mère EnfantWWWilliam R. WilcoxEmory University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Eng et al. (2001) studied this question.

synapsesocial.com/papers/69d7df2633ca018b39ae2fefhttps://doi.org/10.1056/nejm200107053450102
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase1993 · 75 citations
  2. 2Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors1993 · 498 citations